AVEO PHARMACEUTICALS INC (AVEO) Stock Analyst Ratings
USA - NASDAQ:AVEO - US0535883070 - Common Stock
15 USD
0 (0%)
15 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 50% to AVEO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.3. This target is 2% above the current price.
AVEO was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about AVEO.
In the previous month the buy percentage consensus was at a similar level.
AVEO was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-08 | Stifel | Downgrade | Buy -> Hold |
| 2022-10-31 | JonesTrading | Downgrade | Buy -> Hold |
| 2022-10-24 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-10-19 | Baird | Downgrade | Outperform -> Neutral |
| 2022-10-18 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-07-12 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-11 | SVB Leerink | Maintains | Outperform |
AVEO PHARMACEUTICALS INC / AVEO FAQ
What is the price target for AVEO stock?
10 analysts have analysed AVEO and the average price target is 15.3 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 15.
How do analysts rate AVEO PHARMACEUTICALS INC (AVEO)?
The consensus rating for AVEO PHARMACEUTICALS INC (AVEO) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.